Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus

ClinicalTrials.gov ID: NCT02093221

Public ClinicalTrials.gov record NCT02093221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus

Study identification

NCT ID
NCT02093221
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Grifols Therapeutics LLC
Industry
Enrollment
76 participants

Conditions and interventions

Interventions

  • 180 mg/kg Alpha1-PI Biological
  • 90 mg/kg Alpha1-PI Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
6 Years to 35 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2014
Primary completion
Dec 31, 2016
Completion
May 31, 2017
Last update posted
Sep 4, 2018

2014 – 2017

United States locations

U.S. sites
36
U.S. states
24
U.S. cities
31
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724
Clinica Medica San Miguel Los Angeles California 90015
Diabetes Associates Medical Group Orange California 92868
Rady Children's Hospital San Diego San Diego California 92123
Metabolic Institute of America Tarzana California 91356
Ronald H Chochinov MD Ventura California 93003
Yale New Haven Hospital New Haven Connecticut 06511
Christiana Care Health Services Newark Delaware 19713
Solutions Through Advanced Research Inc. Jacksonville Florida 32258
CCM Clinical Research Miami Florida 33133
Advanced Pharma CR LLC Miami Florida 33136
Atlanta Diabetes Associates Atlanta Georgia 30309
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404
Cook County Hospital Chicago Illinois 60612
Methodist Research Institute Indianapolis Indiana 46202
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Louisville Louisville Kentucky 40202
Barry J. Reiner MD, LLC. Baltimore Maryland 21229
UMass Memorial Medical Center Worcester Massachusetts 01655
Wayne State University Detroit Michigan 48201
Children's Hospitals and Clinics of Minnesota Saint Paul Minnesota 55102
Morristown Medical Center Morristown New Jersey 07962
University of New Mexico, Health Sciences Center Albuquerque New Mexico 87131-0001
Women and Children's Hospital Buffalo New York 14222
WakeMed Children's Hospital Raleigh North Carolina 27610
Endocrinology Associates Inc Columbus Ohio 43201
Ohio State University Columbus Ohio 43210
Pediatric Endocrinology, Genetics & Metabolism Oklahoma City Oklahoma 73112
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19106
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Rapid City Regional Hospital/Health Clinical Research Rapid City South Dakota 57701
Research Institute of Dallas Dallas Texas 75231
University of Texas Southwestern Medical Center Dallas Texas 75390
Northeast Clinical Research of San Antonio LLC San Antonio Texas 78154
University of Texas Health Science Center San Antonio Texas 78229
Consano Clinical Research San Antonio Texas 78232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02093221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02093221 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →